Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells

NCT03618472 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metformin
CA Endometrium

Interventions

DRUG: Metformin Hydrochloride 850 MG
DRUG: Placebo Oral Tablet

Sponsor

Department of Medical Services Ministry of Public Health of Thailand